After first move in March 2019 to interim premises, the European Medicines Agency (EMA) is preparing to move to its final premises in Amsterdam, in the Netherlands. EMA Executive Director Guido Rasi signed the lease on 15 November and received the keys to the Agency's new premises.
This transfer was made necessary following Brexit and the need to repatriate all EU agencies to the territory of the Twenty-Seven (see EUROPE B11908A1, B12125A17, B12173A4).
Now that the Zuidas building has...